InnoCentive, Inc. and Prize4Life Announce First Five Awards for Phase I of the Amyotrophic Lateral Sclerosis (ALS) Biomarker Challenge
ANDOVER, Mass.--(BUSINESS WIRE)--InnoCentive, the global leader in open innovation sourcing, announced today that five Solvers have been chosen to receive prizes for the first phase of the Prize4Life ALS Biomarker Challenge. The five winners will receive $15,000 each for their proposals on how to identify an ALS biomarker. Three of the Solvers are from the U.S. and two from Europe.